Ivosidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH1

NCT05030441 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Clonal Cytopenia of Undetermined Significance

Interventions

DRUG: Ivosidenib

Sponsor

Washington University School of Medicine

Collaborators

[object Object]
[object Object]